Last updated 2 months ago
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
1040 patients around the world
Available in Argentina, United States, Mexico
Arcus Biosciences, Inc.
5Research sites
1040Patients around the world
This study is for people with
Gastric cancer
Esophageal cancer
Gastroesophageal cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Instituto de Investigaciones Clínicas Mar del Plata
Recruiting
Clinical Medical Research S.C.
Recruiting
CENEIT Oncológicos. Centro Especializado en Investigación y Tratamientos Oncológicos
Recruiting
Centro de Atención e Investigación Clínica en Oncología - Mérida
Recruiting
Centro Médico Zambrano Hellion
Recruiting
StudySTAR-221
SponsorArcus Biosciences, Inc.
Conditions
Gastric cancerEsophageal cancerGastroesophageal cancer
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05568095
